InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: guardiangel post# 24113

Monday, 10/20/2014 12:51:50 AM

Monday, October 20, 2014 12:51:50 AM

Post# of 30046
This was a nice post about the partnership of Radient and Provista Diagnostics that tells the true story about what continues to develop behind the scenes under the disguise of GCDX. GCDX has no lung cancer test, unless ProvistaDX and Radient agreed to give it to William..We know that can't be true, because William stated in an email someone posted here recently. "William allegedly claims to have no ties to Radient." We know that is a joke...imo Wolf ahooololooooooo

guardiangel Sunday, 07/20/14 03:25:47 PM
Re: guardiangel post# 24112
Post # of 25686
What is "The New Generation Onko-Sure"

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104462823

"Radient has also begun rolling out a lung cancer screening kit called LC Sentinal in the US with partner, Provista Diagnostics. This kit was co-developed by the two companies and is based on the same technology as Onko-Sure. Provista intends to market the kit initially as a laboratory developed test, in which case, each individual laboratory using the kit will need to validate the test prior to its use. The companies will seek FDA approval for the kit in 2011; once this happens, kits can be marketed much more broadly without the need for validations from individual labs."

"It should be noted that Radient is in the process of purchasing Provista Diagnostics, though the terms have not been finalized. The merger will provide Radient with full control of the LC Sentinal test along additional breast cancer and woman’s reproductive cancer tests. This is a natural fit considering the strong ties and synergies between the two companies".

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.